Emerald Mutual Fund Advisers Trust Oyster Point Pharma, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$17.92 - $25.86 $2.13 Million - $3.07 Million	-118,715 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$18.13 - $25.18 $4.04 Million - $5.6 Million	-222,568 Reduced 65.22%	118,715 $2.23 Million
Q3 2020 Oct 28, 2020	BUY	$17.83 - $29.12 $775,533 - $1.27 Million	43,496 Added 14.61%	341,283 $7.2 Million
Q2 2020 Jul 28, 2020	BUY	$27.86 - $35.93 $2.72 Million - $3.5 Million	97,494 Added 48.68%	297,787 $8.6 Million
Q1 2020 Apr 30, 2020	SELL	$23.65 - $40.96 $4.02 Million - $6.96 Million	-169,913 Reduced 45.9%	200,293 $7.01 Million
Q4 2019 Jan 29, 2020	BUY	$13.55 - $26.15 $5.02 Million - $9.68 Million	370,206 New	370,206 $9.05 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.